Markets:

Overview

News

Currencies

International

Treasuries

Intensity Therapeutics, Inc. - Common Stock (NQ:INTS)

6.585 -0.215 (-3.16%)

Streaming Delayed Price Updated: 11:55 AM EST, Feb 25, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Intensity Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

February 13, 2026

Via Chartmill

Let's take a look at the stocks that are in motion in today's session. ↗

February 13, 2026

Via Chartmill

Traders are paying attention to the gapping stocks in Friday's session. ↗

February 13, 2026

Via Chartmill

Why Did INTS Stock Plummet 30% Pre-Market Today? ↗

February 13, 2026

Intensity Therapeutics announced a 1-for-25 reverse stock split, consolidating every 25 existing shares into a single new share.

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 31, 2025

Via Benzinga

Which stocks are experiencing notable movement on Friday? ↗

October 31, 2025

Intrigued by the market activity one hour before the close of the markets on Friday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

These stocks are making the most noise in today's session. ↗

October 31, 2025

Curious about the most active stocks in today's session? Get a glimpse into the stocks that are generating the highest trading volume and capturing market attention.

Via Chartmill

These stocks have an unusual volume in today's session ↗

October 31, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗

October 31, 2025

Via Benzinga

Topics Stocks

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

October 31, 2025

Curious to know what's happening on the US markets in the middle of the day on Friday? Join us as we explore the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 31, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

October 31, 2025

Let's have a look at the gap up and gap down stocks in today's session.

Via Chartmill

Discover the top movers in Friday's pre-market session. ↗

October 31, 2025

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Why Amazon Shares Are Trading Higher By Over 12%; Here Are 20 Stocks Moving Premarket ↗

October 31, 2025

Via Benzinga

Intensity Therapeutics Stock Cools After-Hours Following 395% Surge: What You Should Know ↗

October 31, 2025

Intensity Therapeutics shares plunged 31.9% after-hours following the publication of Phase 1/2 trial results for its cancer therapy INT230-6.

Via Benzinga

Top movers in Thursday's after hours session ↗

October 30, 2025

The regular session of the US market on Thursday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 30, 2025

Via Benzinga

Check out the stocks that are attracting the most attention and driving market activity. ↗

October 30, 2025

Let's dive into the action on the US markets on Thursday. Here are the most active stocks that are driving the market today.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 30, 2025

Via Benzinga

Why Is Retail Going Gaga Over INTS Stocks Today? ↗

October 30, 2025

The firm announced positive data from a study of INT230-6 in the treatment of metastatic and refractory cancers, with 15 of 64 patients in the trial surviving for more than 21 months.

Via Stocktwits

Nasdaq Falls Over 1%; Alphabet Posts Upbeat Earnings ↗

October 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 30, 2025

Via Benzinga

Connecticut Biotech Firm Intensity Therapeutics Navigates Critical Reverse Stock Split

October 24, 2025

Shelton, CT – October 24, 2025 – Intensity Therapeutics Inc. (NASDAQ: INTS), a clinical-stage biotechnology company based in Shelton, Connecticut, is proceeding with a pivotal reverse stock split plan,...

Via MarketMinute

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

October 01, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

September 10, 2025

Via Benzinga

Stay updated with the stocks that are on the move in today's after-hours session. ↗

August 20, 2025

Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics.

Via Chartmill

Intensity (INTS) Q2 Net Loss Drops 50% ↗

August 07, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 09, 2025

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.